久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • FDA approves Novartis’ Gilenya for paediatric use pharmatimes
    May 15, 2018
    US regulators have approved Novartis’ Gilenya to treat children and adolescents with relapsing forms of multiple sclerosis (RMS), making it the first disease-modifying therapy indicated for this patient group.
PharmaSources Customer Service